In Phase 2, age ≥65 years remained significantly associated with moderate II or higher disease across all models, antipsychotic use showed a robust positive association, and the effect of aspiration pneumonia was strong in unadjusted models but attenuated to borderline significance after multivariable adjustment.
← all excerpts
A retrospective risk factor analysis in psychiatric inpatients with COVID-19 from 2020 to 2023 at a neuropsychiatric hospital in Tokyo.
1
—
—